{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-156049","form_type":"8-K","ticker":"STOK","cik":"0001623526","company_name":"Stoke Therapeutics, Inc.","filed_at":"2024-06-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.295634+00:00","generated_at":"2026-06-01T05:54:45.036625+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Stoke Therapeutics shareholders elect three Class II directors, ratify KPMG as auditor","bullets":["Elected Jennifer C. Burstein, Arthur A. Levin, Ph.D., and Ian F. Smith as Class II directors for three-year terms.","Burstein received 32,396,633 votes for; Levin 25,556,568 for; Smith 33,961,032 for; broker non-votes 5,561,508 each.","Ratified KPMG as independent auditor for fiscal 2024 with 39,911,634 votes for, 6,826 against, 9,898 abstentions."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-156049","json":"https://secwatch.observer/filing/0001193125-24-156049.json","markdown":"https://secwatch.observer/filing/0001193125-24-156049.md","text":"https://secwatch.observer/filing/0001193125-24-156049.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1623526/000119312524156049/0001193125-24-156049-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1623526/000119312524156049/d795894d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T05:54:45.036625+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}